BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 29136437)

  • 1. Insulin Analogues and Hypoglycemia in Patients With Type 1 Diabetes.
    Zulewski H; Keller U
    JAMA; 2017 Nov; 318(18):1828. PubMed ID: 29136437
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin Analogues and Hypoglycemia in Patients With Type 1 Diabetes-Reply.
    Lane W; Bailey TS; Gerety G
    JAMA; 2017 Nov; 318(18):1828-1829. PubMed ID: 29136440
    [No Abstract]   [Full Text] [Related]  

  • 3. Preventing exercise-induced hypoglycaemia in insulin-dependent diabetes.
    Chacko E
    Diabetologia; 2016 Nov; 59(11):2487-2488. PubMed ID: 27567625
    [No Abstract]   [Full Text] [Related]  

  • 4. Type 1 diabetes mellitus: effective insulin strategies with less hypoglycemia.
    Bolli GB
    Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):13-20. PubMed ID: 19667675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 Diabetes, Hypoglycemia, and Basal Insulins: Ongoing Challenges.
    Blumer I; Clement M
    Clin Ther; 2017 Aug; 39(8S2):S1-S11. PubMed ID: 27871780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin detemir: a new basal insulin analogue.
    Soran H; Younis N
    Diabetes Obes Metab; 2006 Jan; 8(1):26-30. PubMed ID: 16367879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial.
    Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Christiansen JS; Jensen T; Hougaard P; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
    Diabetes Metab; 2016 Sep; 42(4):249-55. PubMed ID: 27068361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs.
    Rossetti P; Porcellati F; Bolli GB; Fanelli CG
    Diabetes Care; 2008 Feb; 31 Suppl 2():S113-20. PubMed ID: 18227470
    [No Abstract]   [Full Text] [Related]  

  • 10. Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practice.
    Goldman J; Kapitza C; Pettus J; Heise T
    Curr Med Res Opin; 2017 Oct; 33(10):1821-1831. PubMed ID: 28537449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconsideration of severe hypoglycemic events in the treat-to-target trial.
    Dailey G; Strange P; Riddle M
    Diabetes Technol Ther; 2009 Aug; 11(8):477-9. PubMed ID: 19698059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-acting insulin analogs: progressing slowly].
    Holleman F; Hoekstra JB
    Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1668-9. PubMed ID: 15453117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin therapy in diabetes mellitus: how can the currently available injectable insulins be most prudently and efficaciously utilised?
    Bell DS
    Drugs; 2007; 67(13):1813-27. PubMed ID: 17722952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing hypoglycaemia with insulin analogues.
    Heller S
    Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 3():S31-6. PubMed ID: 12174321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of hypoglycemic brittle diabetes with peripheral edema successfully managed by conversion from insulin lispro to insulin aspart.
    Tone A; Shikata K; Nakagawa K; Hashimoto M; Makino H
    Diabetes Res Clin Pract; 2008 Sep; 81(3):e15-6. PubMed ID: 18676048
    [No Abstract]   [Full Text] [Related]  

  • 17. New Insulins and New Aspects in Insulin Delivery.
    Woo VC
    Can J Diabetes; 2015 Aug; 39(4):335-43. PubMed ID: 26233724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-acting insulin analogs: progressing slowly].
    Geelhoed-Duijvestijn PH
    Ned Tijdschr Geneeskd; 2004 Nov; 148(45):2248; author reply 2248-9. PubMed ID: 15568634
    [No Abstract]   [Full Text] [Related]  

  • 19. Innovative insulins--where do analogues fit?
    Phillips LK; Phillips PJ
    Aust Fam Physician; 2006 Dec; 35(12):969-73. PubMed ID: 17149471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poisoning with insulin glargine.
    Brvar M; Mozina M; Bunc M
    Clin Toxicol (Phila); 2005; 43(3):219-20. PubMed ID: 15902802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.